Charles Schwab’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.8M Buy
1,357,117
+44,260
+3% +$1.46M 0.01% 1169
2025
Q1
$52.8M Sell
1,312,857
-22,332
-2% -$898K 0.01% 1039
2024
Q4
$62.8M Buy
1,335,189
+13,798
+1% +$649K 0.01% 964
2024
Q3
$69.8M Buy
1,321,391
+395,709
+43% +$20.9M 0.01% 880
2024
Q2
$50.2M Buy
925,682
+150,126
+19% +$8.13M 0.01% 1075
2024
Q1
$54.4M Sell
775,556
-14,413
-2% -$1.01M 0.01% 984
2023
Q4
$66M Buy
789,969
+33,257
+4% +$2.78M 0.02% 794
2023
Q3
$22.3M Sell
756,712
-14,366
-2% -$423K 0.01% 1444
2023
Q2
$25.2M Buy
771,078
+48,397
+7% +$1.58M 0.01% 1330
2023
Q1
$25.4M Sell
722,681
-3,401
-0.5% -$120K 0.01% 1285
2022
Q4
$33.3M Buy
726,082
+20,870
+3% +$956K 0.01% 1083
2022
Q3
$34.2M Buy
705,212
+98,217
+16% +$4.76M 0.01% 1008
2022
Q2
$23.8M Buy
606,995
+6,503
+1% +$256K 0.01% 1266
2022
Q1
$22.1M Buy
600,492
+15,826
+3% +$583K 0.01% 1467
2021
Q4
$26.6M Sell
584,666
-26,867
-4% -$1.22M 0.01% 1360
2021
Q3
$21.9M Buy
611,533
+100,229
+20% +$3.58M 0.01% 1516
2021
Q2
$10.1M Buy
511,304
+37,785
+8% +$748K ﹤0.01% 1994
2021
Q1
$11M Buy
473,519
+15,337
+3% +$357K ﹤0.01% 1907
2020
Q4
$9.52M Buy
458,182
+9,331
+2% +$194K ﹤0.01% 1895
2020
Q3
$9.72M Buy
448,851
+59,962
+15% +$1.3M ﹤0.01% 1715
2020
Q2
$9.17M Buy
388,889
+21,354
+6% +$503K ﹤0.01% 1707
2020
Q1
$4.33M Buy
367,535
+9,013
+3% +$106K ﹤0.01% 1902
2019
Q4
$3.8M Buy
358,522
+6,501
+2% +$69K ﹤0.01% 2167
2019
Q3
$4.01M Buy
352,021
+22,196
+7% +$253K ﹤0.01% 2091
2019
Q2
$3.71M Buy
329,825
+38,606
+13% +$434K ﹤0.01% 2115
2019
Q1
$2.36M Buy
291,219
+6,464
+2% +$52.3K ﹤0.01% 2306
2018
Q4
$1.8M Sell
284,755
-5,739
-2% -$36.3K ﹤0.01% 2365
2018
Q3
$2.86M Buy
290,494
+38,689
+15% +$381K ﹤0.01% 2305
2018
Q2
$2.09M Buy
251,805
+25,813
+11% +$214K ﹤0.01% 2364
2018
Q1
$1.63M Sell
225,992
-19,801
-8% -$143K ﹤0.01% 2390
2017
Q4
$2M Sell
245,793
-57,554
-19% -$469K ﹤0.01% 2299
2017
Q3
$4.4M Buy
303,347
+23,142
+8% +$336K ﹤0.01% 1937
2017
Q2
$3.39M Buy
280,205
+121,109
+76% +$1.47M ﹤0.01% 2012
2017
Q1
$2.05M Buy
159,096
+31,654
+25% +$407K ﹤0.01% 2191
2016
Q4
$1.55M Buy
127,442
+7,238
+6% +$88K ﹤0.01% 2282
2016
Q3
$1.1M Buy
120,204
+63,104
+111% +$580K ﹤0.01% 2383
2016
Q2
$542K Hold
57,100
﹤0.01% 2561
2016
Q1
$403K Hold
57,100
﹤0.01% 2666
2015
Q4
$598K Buy
57,100
+11,200
+24% +$117K ﹤0.01% 2567
2015
Q3
$308K Hold
45,900
﹤0.01% 2820
2015
Q2
$309K Hold
45,900
﹤0.01% 2866
2015
Q1
$312K Hold
45,900
﹤0.01% 2819
2014
Q4
$368K Hold
45,900
﹤0.01% 2758
2014
Q3
$162K Hold
45,900
﹤0.01% 2994
2014
Q2
$220K Hold
45,900
﹤0.01% 2967
2014
Q1
$437K Buy
45,900
+10,600
+30% +$101K ﹤0.01% 2638
2013
Q4
$230K Hold
35,300
﹤0.01% 2919
2013
Q3
$265K Buy
+35,300
New +$265K ﹤0.01% 2807